Angela Hartley Brodie
Personal Information
Born: 1934
Died: 2017
Country of Birth: Great Britain
Nationality: Great Britain; USA
Ethnicity: White
Education
1956, BAc,1959, MAc Biochemistry, University of Sheffield; 1961, PhD Chemical Pathology, University of Manchester
Professional Life
Field of Study: Biochemistry; Cancer Research
Institution/Corporation: Worcester Foundation for Experimental Biology; University of Maryland School of Medicine; Greenbaum Enterprises, Inc
Degrees & Memberships: Member: 2013, Fellow American Association for Cancer Researc (AACR)
Awards & Achievements
Awards: 2023, National Inventors Hall of Fame; 2005, Charles F. Kettering Prize; 2006, Dorothy P. Landon-AACR Prize;2000, Komen Brinker Award for Scientific Distinction; 2012, Pharmacia Award of the American Society for Experimental Therapeutics; 1998, Pharmacia & Upjohn International Award for Excellence in Published Clinical Research; 2006, Health Care Heroes Award, The Daily Record Newspaper; 2007, Gregory Pincus Medal, University of Massachusetts Medical School; 2010, Jacob Heskel Gabbay Award in Biotechnology & Medicine; 2010, Jill Rose Award for Distinguished Scientific Achievement; 2011, Robert J. & Claire Pasarow Foundation Medical Research Award; 2012, American Society for Pharmacology & Experimental Therapeutic (ASPET) Award
Achievements: Steroidal aromatase inhibitors in cancer research; 1st woman to ever receive the Kettering Prize;
Developed the 1st aromatase inhibitor (formestane) to combat breast cancer
Worked on oral contraceptives for 17 years before switching to focus on the effects of aromatase on breast cancer
Was educated at Quaker boarding schools before going to university
1st woman awarded the Kettering Prize
Her hobbies were horseback riding, hiking, & gardening